BRPI0518786A2 - formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete - Google Patents
formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tableteInfo
- Publication number
- BRPI0518786A2 BRPI0518786A2 BRPI0518786-9A BRPI0518786A BRPI0518786A2 BR PI0518786 A2 BRPI0518786 A2 BR PI0518786A2 BR PI0518786 A BRPI0518786 A BR PI0518786A BR PI0518786 A2 BRPI0518786 A2 BR PI0518786A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical formulation
- capsule
- tablet
- product
- preparing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
FORMULAÇçO FARMACÊUTICA, PROCESSO PARA PREPARAR UMA FORMULAÇçO FARMACÊUTICA, PRODUTO, E, CÁPSULA OU TABLETE. A presente invenção se refere a formulações de dosagem sólidas que incluem ligantes ER<225>-se1etivos que contêm benzoxazol, e processos para fabricação de ditas formulações, mais particularmente a novas formulações e processos para fabricação de formulações contendo o ligante ER<225>-seletivo, ERB-041.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63237504P | 2004-12-02 | 2004-12-02 | |
PCT/US2005/043407 WO2006060532A2 (en) | 2004-12-02 | 2005-11-30 | Formulations of substituted benzoxazoles |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0518786A2 true BRPI0518786A2 (pt) | 2008-12-09 |
Family
ID=36565706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0518786-9A BRPI0518786A2 (pt) | 2004-12-02 | 2005-11-30 | formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete |
Country Status (22)
Country | Link |
---|---|
US (1) | US20060121110A1 (pt) |
EP (1) | EP1850833A2 (pt) |
JP (1) | JP2008521919A (pt) |
KR (1) | KR20070089921A (pt) |
CN (1) | CN101128188A (pt) |
AR (1) | AR053653A1 (pt) |
AU (1) | AU2005311823A1 (pt) |
BR (1) | BRPI0518786A2 (pt) |
CA (1) | CA2589033A1 (pt) |
CR (1) | CR9144A (pt) |
GT (1) | GT200500349A (pt) |
IL (1) | IL183393A0 (pt) |
MX (1) | MX2007006564A (pt) |
NI (1) | NI200700139A (pt) |
NO (1) | NO20072636L (pt) |
NZ (1) | NZ555395A (pt) |
PE (1) | PE20061083A1 (pt) |
RU (1) | RU2007120253A (pt) |
SV (1) | SV2006002317A (pt) |
TW (1) | TW200626144A (pt) |
WO (1) | WO2006060532A2 (pt) |
ZA (1) | ZA200705011B (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008533012A (ja) * | 2005-03-08 | 2008-08-21 | ワイス | 2−(3−フルオロ−4−ヒドロキシフェニル)−7−ビニル−1,3−ベンゾキサゾール−5−オールの結晶形成およびエストロゲンレセプターモジュレーターとしてのその使用 |
US20070191442A1 (en) * | 2006-02-14 | 2007-08-16 | Wyeth | Aqueous Pharmaceutical Formulations of ER-beta Selective Ligands |
TW200803850A (en) * | 2006-03-06 | 2008-01-16 | Wyeth Corp | Tablet formulations and processes |
US20070208069A1 (en) * | 2006-03-06 | 2007-09-06 | Wyeth | Pharmaceutical formulations of an anhydrous crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
WO2007103869A2 (en) * | 2006-03-06 | 2007-09-13 | Wyeth | Liquid and semi-solid pharmaceutical formulations and processes |
US20070207202A1 (en) * | 2006-03-06 | 2007-09-06 | Wyeth | Pharmaceutical formulations of a monohydrate crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
US20080175901A1 (en) * | 2006-11-21 | 2008-07-24 | Wyeth | Pharmaceutical formulations of a crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
US20080175900A1 (en) * | 2006-11-21 | 2008-07-24 | Wyeth | Pharmaceutical formulations of an anhydrate crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
US20080241234A1 (en) * | 2006-11-21 | 2008-10-02 | Wyeth | Pharmaceutical formulations of an anhydrate crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
GB0814953D0 (en) * | 2008-08-18 | 2008-09-24 | Unilever Plc | Improvements relating to nanodisperse compositions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6331562B1 (en) * | 1998-12-30 | 2001-12-18 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
JP2004524289A (ja) * | 2000-12-22 | 2004-08-12 | アストラゼネカ・アクチエボラーグ | 治療化合物 |
UA83620C2 (ru) * | 2001-12-05 | 2008-08-11 | Уайт | Замещенные бензоксазолы и их аналоги как эстрогенные агенты |
US20050165000A1 (en) * | 2002-04-10 | 2005-07-28 | Robertson Sandra K. | Pharmaceutical compositions containing an hiv integrase inhibitor and a nonionic surfactant |
-
2005
- 2005-11-30 TW TW094142062A patent/TW200626144A/zh unknown
- 2005-11-30 AR ARP050105015A patent/AR053653A1/es unknown
- 2005-11-30 MX MX2007006564A patent/MX2007006564A/es unknown
- 2005-11-30 NZ NZ555395A patent/NZ555395A/en unknown
- 2005-11-30 JP JP2007544494A patent/JP2008521919A/ja not_active Withdrawn
- 2005-11-30 KR KR1020077012194A patent/KR20070089921A/ko not_active Application Discontinuation
- 2005-11-30 RU RU2007120253/15A patent/RU2007120253A/ru not_active Application Discontinuation
- 2005-11-30 CA CA002589033A patent/CA2589033A1/en not_active Abandoned
- 2005-11-30 SV SV2005002317A patent/SV2006002317A/es unknown
- 2005-11-30 WO PCT/US2005/043407 patent/WO2006060532A2/en active Application Filing
- 2005-11-30 BR BRPI0518786-9A patent/BRPI0518786A2/pt not_active IP Right Cessation
- 2005-11-30 PE PE2005001386A patent/PE20061083A1/es not_active Application Discontinuation
- 2005-11-30 EP EP05852593A patent/EP1850833A2/en not_active Withdrawn
- 2005-11-30 CN CNA2005800474844A patent/CN101128188A/zh not_active Withdrawn
- 2005-11-30 GT GT200500349A patent/GT200500349A/es unknown
- 2005-11-30 AU AU2005311823A patent/AU2005311823A1/en not_active Abandoned
- 2005-11-30 US US11/290,197 patent/US20060121110A1/en not_active Abandoned
-
2007
- 2007-05-23 CR CR9144A patent/CR9144A/es not_active Application Discontinuation
- 2007-05-24 NO NO20072636A patent/NO20072636L/no not_active Application Discontinuation
- 2007-05-24 IL IL183393A patent/IL183393A0/en unknown
- 2007-05-31 NI NI200700139A patent/NI200700139A/es unknown
- 2007-06-01 ZA ZA200705011A patent/ZA200705011B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL183393A0 (en) | 2007-09-20 |
PE20061083A1 (es) | 2006-11-14 |
NI200700139A (es) | 2008-05-09 |
NO20072636L (no) | 2007-08-13 |
EP1850833A2 (en) | 2007-11-07 |
WO2006060532A3 (en) | 2006-11-16 |
GT200500349A (es) | 2006-07-03 |
AU2005311823A1 (en) | 2006-06-08 |
CA2589033A1 (en) | 2006-06-08 |
TW200626144A (en) | 2006-08-01 |
ZA200705011B (en) | 2010-01-27 |
US20060121110A1 (en) | 2006-06-08 |
JP2008521919A (ja) | 2008-06-26 |
RU2007120253A (ru) | 2009-01-10 |
SV2006002317A (es) | 2006-06-26 |
CR9144A (es) | 2007-11-23 |
AR053653A1 (es) | 2007-05-16 |
WO2006060532A2 (en) | 2006-06-08 |
MX2007006564A (es) | 2007-06-19 |
KR20070089921A (ko) | 2007-09-04 |
NZ555395A (en) | 2009-07-31 |
CN101128188A (zh) | 2008-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0518786A2 (pt) | formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete | |
BRPI0518789A2 (pt) | formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete | |
BRPI0518790A2 (pt) | formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete | |
AR052925A1 (es) | Forma cristalina betad del clorhidrato de ivabradina, un procedimiento para su preparacion y composiciones farmaceuticas que la contienen | |
ATE556074T1 (de) | Neue imidazoä1,5-aüpyridinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten | |
NO20064041L (no) | Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter | |
PL1842534T3 (pl) | Tabletki bursztynianu metoprololu o przedłużonym uwalnianiu oraz sposoby ich wytwarzania | |
EA200600320A1 (ru) | γ-КРИСТАЛЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ | |
EP1726299A3 (en) | Cores and microcapsules suitable for parenteral administration as well as process for their manufacture | |
CR11740A (es) | Composiciones que comprenden fármacos levemente básicos y formas de dosificación de liberación controlada | |
CY1110115T1 (el) | Παραγωγα ακετυλενυλο-πυραζολο-πυριμιδινης ως mglur2 ανταγωνιστες | |
BRPI0507790A (pt) | composto de pirazolina substituìda, processo para a sua manufatura, medicamentos e seus usos | |
ATE482194T1 (de) | Indolonderivate, verfahren zu deren herstellung und deren anwendungen | |
IL204052A (en) | Annotation of 1,1,1 - Tripluoro - 2 - Hydroxy - 3 - Phenylpropane | |
MXPA04003636A (es) | Composiciones farmaceuticas que comprenden acido micofenolico o sal de micofenolato. | |
UA104988C2 (uk) | Похідні піроніндолу та спосіб їх отримання | |
BRPI0615195A8 (pt) | preparação farmacêutica, embalagem, e, métodos para tratar doença gastrintestinal, para fabricar uma cápsula e para testar dissolução de cápsulas de balsalazida. | |
UA103179C2 (ru) | Фармацевтическая композиция, которая содержит эзетимиб | |
UY27548A1 (es) | Sales de ácido succínico de 5,7,14-triazatetraciclo (10.3.1.02.11.04,9) exadeca-2 (11),3,5,7,9-pentaeno y composiciones farmacéuticas | |
CY1111256T1 (el) | Παραγωγα αζαδικυκλοοκταν-3-ονης και χρηση τους | |
TNSN07337A1 (en) | Pharmaceutical composition comprising an indolylmaleimide derivative | |
AR061093A1 (es) | Composiciones de calcio | |
TW200718698A (en) | Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof | |
ECSP066860A (es) | Formulaciones de matriz oral que comprenden licarbazepina | |
UA90504C2 (ru) | Лекарственное средство для лечения заболеваний дыхательных путей |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012. |